Elkfork Partners’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Elkfork Partners’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$188K	Buy	14,476 +440	+3%	+$5.31K	﹤0.01%	839
2019 Q2	$175K	Hold	14,036	–	–	﹤0.01%	860
2019 Q1	$204K	Buy	14,036 +66	+0.5%	+$843	0.01%	799
2018 Q4	$154K	Buy	13,970 +4,268	+44%	+$59.4K	﹤0.01%	825
2018 Q3	$255K	Buy	9,702 +1,364	+16%	+$36.9K	0.01%	787
2018 Q2	$171K	Hold	8,338	–	–	﹤0.01%	834
2018 Q1	$151K	Buy	8,338 +44	+0.5%	+$734	﹤0.01%	857
2017 Q4	$116K	Buy	8,294 +572	+7%	+$7.73K	﹤0.01%	915
2017 Q3	$143K	Buy	7,722 +2,354	+44%	+$39.4K	﹤0.01%	822
2017 Q2	$91K	Buy	5,368 +2,772	+107%	+$42.2K	﹤0.01%	886
2017 Q1	$35K	Sell	2,596 -484	-16%	-$7.58K	﹤0.01%	957
2016 Q4	$46K	Buy	+3,080	New	+$40.7K	﹤0.01%	890

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Elkfork Partners's MNTA Position: Q3 2019 in Review

Elkfork Partners increased its Momenta Pharmaceuticals, Inc. (MNTA) stake by 3.1% in Q3 2019, buying an estimated $5.31K and bringing the position to 14,476 shares worth $188K. The position accounts for ﹤0.01% of the portfolio, ranked #839.

Elkfork Partners first reported a position in MNTA in Q4 2016 and has held it in 12 quarters since. The position peaked at $255K in Q3 2018. 154 funds tracked by Wall St. Rank hold MNTA as of Q3 2019.

Elkfork Partners held 14,476 shares of Momenta Pharmaceuticals, Inc. worth $188K as of Q3 2019.
Elkfork Partners bought 440 Momenta Pharmaceuticals, Inc. shares in Q3 2019, an estimated $5.31K.
Momenta Pharmaceuticals, Inc. made up ﹤0.01% of Elkfork Partners's portfolio in Q3 2019, its #839 holding.
Elkfork Partners first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2016 and has held it in 12 quarters since.
Elkfork Partners's Momenta Pharmaceuticals, Inc. position peaked at $255K in Q3 2018.
154 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.